{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,8]],"date-time":"2026-05-08T01:37:03Z","timestamp":1778204223378,"version":"3.51.4"},"reference-count":14,"publisher":"Wiley","issue":"1","license":[{"start":{"date-parts":[[2015,9,1]],"date-time":"2015-09-01T00:00:00Z","timestamp":1441065600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Am J Addict"],"published-print":{"date-parts":[[2016,1]]},"DOI":"10.1111\/ajad.12318","type":"journal-article","created":{"date-parts":[[2016,1,5]],"date-time":"2016-01-05T20:33:04Z","timestamp":1452025984000},"page":"25-27","source":"Crossref","is-referenced-by-count":33,"title":["Catatonia secondary to synthetic cannabinoid use in two patients with no previous psychosis"],"prefix":"10.1111","volume":"25","author":[{"given":"Madiha","family":"Khan","sequence":"first","affiliation":[{"name":"Department of Psychiatry; Baylor College of Medicine; Houston Texas"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lauren","family":"Pace","sequence":"additional","affiliation":[{"name":"Department of Psychiatry; Baylor College of Medicine; Houston Texas"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anh","family":"Truong","sequence":"additional","affiliation":[{"name":"Department of Psychiatry; Baylor College of Medicine; Houston Texas"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mollie","family":"Gordon","sequence":"additional","affiliation":[{"name":"Department of Psychiatry; Baylor College of Medicine; Houston Texas"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nidal","family":"Moukaddam","sequence":"additional","affiliation":[{"name":"Department of Psychiatry; Baylor College of Medicine; Houston Texas"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2015,12,28]]},"reference":[{"key":"10.1111\/ajad.12318-BIB0001|ajad12318-cit-0001","article-title":"Synthetic Marijuana. The FBI Law Enforcement Bulletin","author":"Macher","year":"2012","journal-title":"FBI"},{"key":"10.1111\/ajad.12318-BIB0002|ajad12318-cit-0002","unstructured":"2012 http:\/\/www.drugabuse.gov\/publications\/drugfacts\/k2spicesynthetic-marijuana"},{"key":"10.1111\/ajad.12318-BIB0003|ajad12318-cit-0003","doi-asserted-by":"crossref","first-page":"952","DOI":"10.1016\/j.bcp.2012.01.004","article-title":"Monohydroxylated metabolites of the K2 synthetic cannabinoid JWH-073 retain intermediate to high cannabinoid 1 receptor (CB1R) affinity and exhibit neutral antagonist to partial agonist activity","volume":"83.7","author":"Brents","year":"2012","journal-title":"Biochem Pharmacol"},{"key":"10.1111\/ajad.12318-BIB0004|ajad12318-cit-0004","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1002\/phar.1424","article-title":"Not for human consumption\u2019: A review of emerging designer drugs","volume":"34.7","author":"Musselman","year":"2014","journal-title":"Pharmacotherapy"},{"key":"10.1111\/ajad.12318-BIB0005|ajad12318-cit-0005","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1016\/j.expneurol.2011.02.007","article-title":"Prolonged cannabinoid exposure alters GABA(A) receptor mediated synaptic function in cultured hippocampal neurons","volume":"229.2","author":"Deshpande","year":"2011","journal-title":"Exp Neurol"},{"key":"10.1111\/ajad.12318-BIB0006|ajad12318-cit-0006","volume-title":"Catatonia","author":"Kahlbaum","year":"1973"},{"key":"10.1111\/ajad.12318-BIB0007|ajad12318-cit-0007","doi-asserted-by":"crossref","DOI":"10.1017\/CBO9780511543777","volume-title":"Catatonia: A Clinician's Guide to Diagnosis and Treatment","author":"Fink","year":"2003"},{"key":"10.1111\/ajad.12318-BIB0008|ajad12318-cit-0008","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1007\/s40263-014-0143-9","article-title":"Catatonia in patients with autism: Prevalence and management","volume":"28","author":"Mazzone","year":"2014","journal-title":"CNS Drugs"},{"key":"10.1111\/ajad.12318-BIB0009|ajad12318-cit-0009","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1176\/jnp.2007.19.4.406","article-title":"Review of adjunctive glutamate antagonist therapy in the treatment of catatonic syndromes","volume":"19.4","author":"Carroll","year":"2007","journal-title":"J Neuropsychiatry Clin Neurosci"},{"key":"10.1111\/ajad.12318-BIB0010|ajad12318-cit-0010","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/j.psym.2012.06.008","article-title":"Prototypes of catatonia: Diagnostic and therapeutic challenges in general hospital","volume":"54.1","author":"Azzam","year":"2013","journal-title":"Psychosomatics"},{"key":"10.1111\/ajad.12318-BIB0011|ajad12318-cit-0011","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1097\/01.jcp.0000177850.23534.69","article-title":"Prophylactic effect of valproate in the treatment for siblings with catatonia: A case report","volume":"25.5","author":"Yoshida","year":"2005","journal-title":"J Clin Psychopharmacol"},{"key":"10.1111\/ajad.12318-BIB0012|ajad12318-cit-0012","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1176\/jnp.13.2.303","article-title":"Intravenous valproic acid in the treatment of severe catatonia","volume":"13.2","author":"Kruger","year":"2001","journal-title":"J Neuropsychiatry Clin Neurosci"},{"key":"10.1111\/ajad.12318-BIB0013|ajad12318-cit-0013","doi-asserted-by":"crossref","DOI":"10.1097\/YCT.0b013e318290fa36","article-title":"Electroconvulsive therapy (ECT) for catatonia in a patient with schizophrenia and synthetic cannabinoid abuse: A case report","author":"Leibu","year":"2013","journal-title":"J ECT"},{"key":"10.1111\/ajad.12318-BIB0014|ajad12318-cit-0014","first-page":"38","article-title":"Synthetic Marijuana use and development of catatonia in 17-year old male","volume":"97","author":"Smith","year":"2014","journal-title":"Minn Med"}],"container-title":["The American Journal on Addictions"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fajad.12318","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/onlinelibrary.wiley.com\/wol1\/doi\/10.1111\/ajad.12318\/fullpdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,7,3]],"date-time":"2021-07-03T07:59:43Z","timestamp":1625299183000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/ajad.12318"}},"subtitle":["Synthetic Cannabinoid-Induced Catatonia"],"short-title":[],"issued":{"date-parts":[[2015,12,28]]},"references-count":14,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2016,1]]}},"URL":"https:\/\/doi.org\/10.1111\/ajad.12318","archive":["Portico"],"relation":{},"ISSN":["1055-0496"],"issn-type":[{"value":"1055-0496","type":"print"}],"subject":[],"published":{"date-parts":[[2015,12,28]]}}}